pre-seed
Stage
1
Investors
About
KYLYS develops innovative biocompatible and biodegradable hyaluronic acid-based gels for medical and aesthetic injectable treatments, designed to provide long-lasting effects and enhanced safety.
Explore KYLYS's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.